Title: RST DLMP Grand Rounds: Sickle cell disease: How new technologies are transforming patient lives (February 7, 2024)

Speakers: Justin E. Juskewitch, M.D., Ph.D., and Maggie A. DiGuardo, M.D., Assistant Professors of Laboratory Medicine and Pathology

Learning Objectives: After attending this presentation, you should be able to:

1. Describe the prevalence and pathophysiology of sickle cell disease
2. Summarize current clinical management approaches with associated challenges and limitations (clinical case study)
3. State new treatment modalities and potential patient impact

Audience: DLMP Staff

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.